Seminar Series – Remy L. Brim, Ph.D., BGR Group Washington, DC

Event Date & Time

February 19, 2020 at 12:00 Noon

Location

Medschool Long Campus Room 444B


Event Details:

DEPARTMENT OF PHARMACOLOGY SEMINAR SERIES

Co-Sponsored by

Addiction Research Treatment &

Training Center of Excellence

 

Remy L. Brim, Ph.D.

Vice President, Regulatory Policy and Strategy

BGR Group

Washington, DC

Pharmacology, Policy, and Politics

 

Pharmacologists aspire to move their research from bench to bedside. But even after a drug is approved by the FDA, there are myriad players who impact which patients receive it and what it costs. While seemingly obscure, the workings of the drug supply chain and policy proposals aiming to change it, impact everyone from patients to researchers. Dr. Brim will guide an interactive overview of the stakeholders that shape drug development, distribution, dispensing, and payment, and contemplate how federal policy proposals by some 2020 Presidential and Congressional candidates may impact drug innovation and patient care in the future.

For more information, please contact the Department of Pharmacology
Ann Miller at 567-4205 (millera5@uthscsa.edu)

 

Save to Calendar

Add to calendar

About the Speaker(s)

Remy Brim, Ph.D. is a scientist and healthcare policy expert focused primarily on strategic policy and advocacy support for clients with FDA-regulated products and activities. Her passion, deep technical understanding, thoughtfulness and commitment to sound public health policy helps clients effectively navigate the complex regulatory and political landscapes required to advance the discovery, development and delivery of innovative products to patients and consumers.

Read More >>>